503027-61-0
Chemical Structure
CH401 peptide
- CAS No.: 503027-61-0
- Formula:C114H173N29O32
- Molecular Weight:2461.77
SMILES: O=C([C@@H](N)CC1=CC=C(O)C=C1)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)[C@@H](C)O)=O)CC(C)C)=O)C)=O)CC(C)C)=O)CCC(N)=O)=O)CC(N)=O)=O)CC(N)=O)=O)CCCCN)=O)CC2=CNC=N2)=O)CC3=CC=CC=C3)=O)[C@H](CC)C)=O)CC(O)=O)=O)CCCCN)=O)CC4=CNC5=CC=CC=C45)=O)CC(C)C)=O)[C@H](CC)C)=O)[C@@H](C)O)=O)CC(O)=O)=O)CCC(N)=O
Biological Activity: CH401 peptide is a HER2-derived antigen peptide. After being bound to the artificial viral capsid by a self-assembled β-cyclic peptide, CH401 peptide is encapsulated in a lipid bilayer containing the lipid adjuvant α-GalCer, and can be studied as a self-adjuvant anti-breast cancer vaccine candidate[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CH401 peptide | CH401 peptide is a HER2-derived antigen peptide. After being bound to the artificial viral capsid by a self-assembled β-cyclic peptide, CH401 peptide is encapsulated in a lipid bilayer containing the lipid adjuvant α-GalCer, and can be studied as a self-adjuvant anti-breast cancer vaccine candidate. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
